Aprepitant Capsules:-
PO- The recommended dose is 125 mg, 1 hour prior to chemotherapy treatment (Day 1) and 80 mg orally once daily in the morning on Days 2 and 3. How it should be taken :
It comes as a capsule to take by mouth, with or without food. Special Instruction :
* Caution should be exercised in patients with history of nausea or vomiting, liver disease, any allergy, who are taking other medications, during pregnancy and breastfeeding.
* It may cause dizziness, do not drive a car or operate machinery while taking this medication.
Side Effects :
Body as a Whole - Weakness/fatigue, dizziness, dehydration, abdominal pain and fever.
Gastrointestinal - Nausea, constipation, diarrhea, vomiting, heartburn and stomach discomfort.
ENT - Ringing in the ear.
Blood - Decrease in white blood cells.
Metabolic - Loss of appetite.
Central Nervous System - Headache and sleeplessness. Respiratory - Hiccups.

Price:
Application : Other, Oral administration for cancer treatment
Dosage Form : Tablet
Indication : NonSmall Cell Lung Cancer (NSCLC), Pancreatic Cancer
Ingredients : Other , Erlotinib Hydrochloride and excipients
Shelf Life : 24 months
Feature : Other, Targeted cancer therapy; precise EGFR inhibition
Application : Other, Intravenous use (IV only)
Dosage Form : Injection
Indication : Chronic lymphocytic leukemia, NonHodgkin lymphoma
Ingredients : Other , Bendamustine HCl, excipients
Shelf Life : 24 months
Feature : Other, Lyophilized powder or solution for injection; sterile and pyrogenfree
Application : Other, Oral administration as directed by physician
Dosage Form : Tablet
Indication : Used in treatment of multiple myeloma and erythema nodosum leprosum (ENL)
Ingredients : Other , Thalidomide, excipients
Shelf Life : 24 months from manufacture
Feature : Other, Antiinflammatory and immunomodulatory effect
Application : Other, Anticancer medication
Dosage Form : Tablet
Indication : Used for the treatment of certain types of brain tumours, including glioblastoma multiforme and anaplastic astrocytoma
Ingredients : Other , Temozolomide, Excipients
Shelf Life : 2 years
Feature : Other, Oral chemotherapy agent with proven efficacy in malignant gliomas